Sign up for periodic reports and bulletins
FREE access; FREE of commercials; FREE to use
Posted October 12, 2015: by Bill Sardi
It should not be surprising to learn that the gradual accumulation of iron in the male body should result in undesirable health consequences. After full childhood growth is achieved males accumulate 1 milligram of excess iron per day, which is largely stored in the liver and attached to hemoglobin in red blood cells. By middle age a male has twice as much stored in in his body than an equally aged female who menstruates to control iron. The result is that a male at age 40 has double the risk for diabetes, cancer and heart disease as female of the same age.
With that said, as men approach middle age they might be losing sex drive and feel terribly fatigued. These symptoms may be due to tired iron-overloaded blood. Testosterone shots may remedy desire but not deal with the root of the problem.
Posted October 9, 2015: by Bill Sardi
At a 1999 conclave, executives of the nation’s biggest food companies walked out on a meeting that attempted to get them to share some of the responsibility for the then growing diabesity epidemic. [New York Times Feb 20, 2013] With sugarized bacon, ketchup, peanut butter, wrapped meats, salad dressings and processed foods dominating grocery store shelves, shockingly half the nation now is diabetic or pre-diabetic. [LA Times Sept 8, 2015; Journal American Medical Assn. Sept 8, 2015]
Pre-diabetes means that your blood sugar level is higher than normal but not high enough to be classified as adult-onset (type II) diabetes and you have not developed symptoms yet (eyes, kidneys, heart, pancreas). You are more likely to develop full-blown diabetes within 2 to 10 years. [Mayo Clinic]
Posted September 20, 2015: by Bill Sardi
Why do women experience a steep increase in heart attacks with the onset of menopause? The obvious answer, without checking the science, is the decline in estrogen production has something to do with the dramatic increase in strokes and heart attacks among post-menopausal women.
Despite the obvious benefits of estrogen replacement, the American Heart Association does not recommend postmenopausal hormone therapy to reduce the risk of coronary heart disease or stroke because some studies have failed to show a reduced risk. A spokesperson for the AHA says: “Estrogen decline isn’t the only reason women face a higher cardiovascular disease risk after reaching menopause. We’re trying to figure the rest of it out.” [American Heart Assn]
Posted September 9, 2015: by Bill Sardi
IP6 phytate is an overlooked nutritional factor that is protective against stiffening (calcification) of the first blood vessel (aorta) outside the heart. Stiffening of the aorta is associated with higher systolic (pumping) blood pressure.
The dietary intake of IP6 was recently measured as determined by excretion in urine among senior adults, with the following results:
Posted September 8, 2015: by Bill Sardi
The claim that the health benefits derived from cholesterol-lowering statin drugs “far out-weigh” potential harms among healthy and high-risk patients continues to be echoed throughout modern medicine. [Current Pharmaceutical Design 2015; British Medical Journal July 17, 2014]
But now a warning has been issued by leading researchers that modern medicine re-think its broadened approach to the use of statin drugs among healthy patients. [Daily Mail UK Sept 6, 2015]
Posted September 6, 2015: by Bill Sardi
This may be the high mark among the 100-plus scientific papers and book chapters that Honorary Professor of Medicine & Surgery STIG BENGMARK, MD, PhD, (Lund University in Sweden) has ever written. His most recent written work is published in the August 2015 edition of the journal Hepatobiliary Surgery & Nutrition, August 2015.
Posted August 27, 2015: by Bill Sardi
Today’s news headlines once again attribute recent declines in coronary heart disease mortality to statin drugs and modern treatments like arterial stents.
Citing a report in the European Heart Journal, The Daily Mail, a British publication, mistakenly claims Great Britain has “one of the best records in Europe” with 184 deaths per 100,000 people for coronary heart disease — a dramatic 46.9% decline over the past 10 years. [European Heart Journal Aug 25, 2015; Daily Mail UK Aug 26, 2015] Yet the chart below reveals Great Britain (United Kingdom) isn’t even in the top 10 countries with the lowest death rate for coronary artery disease.
Posted August 25, 2015: by Bill Sardi
A recently published paper indicates macular degeneration begins with low-grade inflammation that activates microglia, cells that are found in the brain and eyes that dispense with waste products and defend against infection. [Journal Leukocyte Biology Aug 20, 2015]
Posted August 21, 2015: by Bill Sardi
Now that the U.S. Supreme Court has ruled that the Freedom of Speech Amendment in the Constitution truly means “freedom of speech,” the aftershock of this ruling is yet to be realized as it reaches far into America, including dietary supplement labels.
Dietary supplement marketers have long been frustrated over the FDA’s narrow rulings regarding health and disease claims on product labels, particularly for obvious dietary deficiency disorders. For example, the label on a bottle of vitamin C pills cannot say their products allay the many prevalent symptoms of scurvy (vitamin C deficiency) even though they have been well documented for decades.
Posted July 27, 2015: by Bill Sardi
It’s a cardiologist’s dream come true. A newly approved $1200/monthly-injectable drug that dramatically reduces circulating cholesterol levels may become the first $100-200 billion medicine.
That would dwarf the record $9 billion annual sales for Lipitor, the statin cholesterol-lowering drug that was the best selling drug of all time until its patent recently expired. And to add value to the equation, this newly FDA-approved drug may be the first cholesterol-lowering medication to actually save lives, but for different reasons than advertised.